IL17A and pancreatic neoplasm: Treatment of pancreatic cancer cell lines MIA PaCa-2 and Panc02 with human respective mouse recombinant IL-17A protein (20 ng/mL) did not change cell motility in the wound healing assay after 24 and 48 h (Figure 2a).